HRT Financial’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-34,242
Closed -$2.74M 4547
2026
Q1
$2.74M Sell
34,242
-131,388
-79% -$10.8M 0.01% 1391
2025
Q4
$14.1M Buy
+165,630
New +$13.6M 0.04% 323
2025
Q3
Sell
-81,657
Closed -$6.39M 3068
2025
Q2
$6.39M Buy
81,657
+76,908
+1,619% +$5.74M 0.03% 446
2025
Q1
$344K Buy
+4,749
New +$340K ﹤0.01% 1701
2024
Q3
Sell
-68,653
Closed -$6.34M 2630
2024
Q2
$6.34M Buy
+68,653
New +$6.08M 0.04% 335
2023
Q4
Sell
-12,742
Closed -$882K 2520
2023
Q3
$882K Sell
12,742
-54,186
-81% -$4.35M 0.01% 1063
2023
Q2
$6.31M Buy
+66,928
New +$5.82M 0.06% 231
2022
Q4
Sell
-75,688
Closed -$6.25M 2652
2022
Q3
$6.25M Buy
+75,688
New +$7.28M 0.07% 236
2021
Q4
Sell
-55,543
Closed -$6.29M 3423
2021
Q3
$6.29M Buy
+55,543
New +$6.34M 0.04% 256
2021
Q1
Sell
-32,421
Closed -$2.96M 2812
2020
Q4
$2.96M Buy
+32,421
New +$2.69M 0.06% 235
2020
Q2
Sell
-53,382
Closed -$3.36M 1597
2020
Q1
$3.36M Buy
+53,382
New +$3.85M 0.22% 85
2019
Q3
Sell
-320,040
Closed -$19.7M 1439
2019
Q2
$19.7M Buy
+320,040
New +$19.4M 1.24% 13

Other funds holding EW

HRT Financial's EW Position: Q2 2026 in Review

HRT Financial sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 34,242 shares — an estimated $2.74M sold.

HRT Financial first reported a position in EW in Q2 2019 and held it in 12 quarters. The position peaked at $19.7M in Q2 2019. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • HRT Financial reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 34,242 Edwards Lifesciences shares in Q2 2026, an estimated $2.74M.
  • HRT Financial first reported a position in Edwards Lifesciences in Q2 2019 and held it in 12 quarters.
  • HRT Financial's Edwards Lifesciences position peaked at $19.7M in Q2 2019.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.